Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

MGX

+ Watchlist+ Portfolio

Metagenomi Therapeutics, Inc.

Regulated industrySells to businessesDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.63
52-Week Range
$0.60 – $1.87
Market Cap
$23.89M
P/E (TTM)
—
EPS (TTM)
-2.50
Dividend Yield
0.00%
Advanced Metrics
Price/Book
0.26
PEG Ratio
—
Return on Equity
-69.35%
Return on Assets
-30.83%
Gross Margin
0.00%
Operating Margin
-1410.57%
Profit Margin
0.00%
Current Ratio
3.43
Debt/Equity
0.39
Total Debt
$36.21M
Free Cash Flow
$-49.82M
Revenue Growth
-74.80%
Earnings Growth
—
Enterprise Value
$-41.58M

Market Snapshot

About

Metagenomi Therapeutics is a genetic medicines company developing gene editing and gene writing therapies. The company uses its proprietary metagenomics platform to discover novel genome editing systems for treating genetic diseases.